Aroa Biosurgery (ARX) Short Interest
Aroa Biosurgery (ASX:ARX) had 0.00% of shares reported as short positions as of 10 Aug 2026, representing 440 shares. Aroa Biosurgery operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Aroa Biosurgery
AROA Biosurgery Limited specializes in regenerative healing products for soft-tissue repair. It emphasizes the use of extracellular matrix (ECM) biomaterials in its offerings, giving it a niche position in the medical devices market. The company aims to improve healing outcomes and reduce healthcare costs, standing out through its innovative solutions and successful commercialization strategies.
Short position
Aroa Biosurgery (ASX:ARX) has 0.00% of its shares on issue reported as short positions as of 10 Aug 2026, or about 440 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has fallen 0.07 percentage points. Its highest recorded short interest was 0.47% in August 2023. ARX is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4ARX intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Aroa Biosurgery
About
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss ARX
Start a research thread or post the first pulse update